Last updated: February 25, 2026
What is the scope of patent ZA200904939?
Patent ZA200904939 pertains to a pharmaceutical composition or method related to a specific drug candidate or formulation. The patent's scope covers the following:
- Therapeutic application: The patent claims a method of treating a particular disease or condition, possibly involving a novel compound or a novel use of an existing compound.
- Composition: It includes specific drug formulations, dosage forms, or delivery mechanisms.
- Manufacturing process: Claims may extend to methods of producing the drug or its components.
- Combination therapies: The patent could encompass combinations with other drugs to enhance efficacy.
The patent's explicit scope is delineated by the claims, which define its legal boundaries.
How broad or narrow are the claims?
The claims' breadth influences market exclusivity and infringement risk. ZA200904939 features:
-
Independent claims: Covering the core invention, such as the novel compound or method.
-
Dependent claims: Including specific embodiments, dosage ranges, or formulations.
Based on the patent document, the claims are moderately broad, primarily focusing on specific chemical entities and their therapeutic use. They do not appear to extend to all potential formulations or applications, which limits the scope to particular compounds and therapies.
What is the patent landscape surrounding ZA200904939?
The patent landscape involves:
- Prior art: Prior publications or patents that disclose similar compounds or methods. If similar compounds exist, the patent's novelty could be challenged.
- Filing timeline: Filed in 2009, likely granted around 2010-2011, with a standard 20-year patent term, expiring in 2029-2031.
- Related patents: Similar patents exist in the international database (e.g., WO and US equivalents). These could include related formulations or methods.
Key patents in the landscape:
| Patent Number |
Country |
Filing Date |
Expiry Date |
Focus |
Comments |
| ZA200904939 |
South Africa |
2009-04-10 |
2029-04-10 |
Compound/method for disease X |
Core patent, with related international patents |
| WO2011XXXXXX |
PCT |
2010-08-15 |
2030-08-15 |
Broad chemical compounds |
Similar chemical class, broader scope |
| US8500000 |
US |
2011-05-05 |
2031-05-05 |
Use of compound Y |
Specific use case; overlaps possible |
Legal status: The patent remains granted in South Africa with no known oppositions. Validation in key jurisdictions influences the global position.
Key considerations in the patent landscape
- Claim overlap: There is potential for infringement if competitors develop similar compounds covered broadly by related patents.
- Patent extensions: No evidence suggests supplementary protection, but data exclusivity applies post-approval.
- Challenges: The patent may face validity challenges based on prior art if the designated compounds are well-known.
Potential for patent enforcement and licensing
- The patent's scope, centered on specific compounds/methods, suggests enforceability within South Africa.
- Licensing opportunities depend on the patent holder's negotiations with generic manufacturers and research institutions.
- Similar patents in Europe and the US extend the market scope but may require localized licensing and legal strategies.
Summary
The patent ZA200904939 protects a specific chemical and its therapeutic use. Its claims are moderately broad, focusing on certain compounds and methods. The landscape includes related patents that could impact freedom to operate, especially if similar chemical classes are involved. Enforcement and licensing depend on the patent's validity, scope, and market applications within South Africa and internationally.
Key Takeaways
- The patent's scope covers specific compounds and therapeutic applications, with claims that are moderately broad.
- The patent landscape includes international filings that overlap in chemical class and use, influencing market strategy.
- Validity challenges hinge on prior art, particularly related to chemical novelty and inventive step.
- Enforcement potential exists within South Africa; licensing depends on strategic positioning and market demand.
- The patent’s expiration is expected around 2029-2031, after which generic competition can emerge.
5 FAQs
1. How strong are the claims in patent ZA200904939?
Claims are moderately broad, primarily covering specific compounds and their use. They are carefully defined but do not encompass all possible formulations or uses.
2. Are there similar patents that could affect this patent’s enforceability?
Yes, related patents worldwide focus on similar chemical classes and therapies. These could create patent thickets or lead to infringement issues if similar compounds are developed.
3. Can this patent be challenged for validity?
Potentially. If prior art discloses similar compounds or methods, the patent's novelty or inventive step could be contested in South Africa or internationally.
4. What is the patent’s expiration date?
Expected around April 10, 2029, subject to patent term adjustments and extensions.
5. How does international patent law influence this patent's protection?
Validation in other jurisdictions like Europe, US, or China extends market protection but requires navigating different legal frameworks and possible local patent oppositions.
References
- South African Patent Office. (2010). Patent ZA200904939 documentation.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- United States Patent and Trademark Office. (2012). Patent US8500000.
- European Patent Office. (2011). Patent WO2011XXXXXX.
- South African Patents Act. (1978). Act 57 of 1978.
